跳至主要内容
临床试验/NCT06370650
NCT06370650Unknown不适用

Effect of Platelet Rich Plasma on Outcome of Narrow Band UVB in Treatment of Vitiligo; Clinical and Histopathological Study

Sohag University1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年12月8日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
30
试验地点
1
主要终点
Improvement of vitiligo

研究概览

简要总结

For each patient, one side of body will be treated with NB-UVB alone while the other side will be treated with NB-UVB therapy in addition to intradermal injection of PRP every 2 weeks. Patients will be photographed at the first visit, in the middle and at the end of therapy. Each patient will sign a written consent form to be included in the study and to be photographed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
15 Years 至 50 Years(Child, Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with stable non segmental vitiligo. (Absence of koebnerization, absence of new lesion and absence of widening of the existing lesions).
  • •Patients have more than 15 years.

排除标准

  • •Patients have active vitiligo (appearance of new lesion, history of koebnerization).
  • •Pregnant and lactating women. History of keloid formation. Anemia (hemoglobin level <10gm/dl), thrombocytopenia (platelet count <100,000 /µL), coagulopathies or patients on anticoagulant therapy and patients with iron deficiency.
  • •Patients taking drugs that prolong bleeding time such as Aspirin and vitamin E Patients taking treatment of vitiligo in last 2 months

研究组 & 干预措施

Narrow band UVB

Active Comparator

干预措施: platelet rich plasma, narrow band UVB (Procedure)

Platelet rich plasma plus narrow band UVB

Active Comparator

干预措施: platelet rich plasma, narrow band UVB (Procedure)

结局指标

主要结局

Improvement of vitiligo

时间窗: within 6 months

increase repigmentation score

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sara Hassan Ahmed

assissant lecturer

Sohag University

研究点 (1)

Loading locations...

相似试验

Effect of Platelet Rich Plasma on Outcome of Narrow... | 临床试验